Most cancer cells are deficient in p53 circuitry, either through p53 missense mutations that confer a dominant-negative function, inactivation of the p53 gene by its promoter methylation, mutations that inactivate ARF and overexpression of MDM243. The gene discussed is CDKN2A; the disease is cancer.